3月5日 - ** 癌症药物开发商iTeos Therapeutics ITOS.O股价在下午的交易中上涨4.5%，至7.15美元。
** 根据LSEG汇编的数据，该公司报告称 (link)，第四季度每股净亏损1.01美元，而分析师预计每股亏损1.06美元。
** ITOS 预计其6.55 亿美元的现金余额将为 其2027 年的发展提供资金支持
** ITOS 在过去 12 个月中下跌了 38.2
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.